Janus Henderson Group PLC Rocket Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 35,253 shares of RCKT stock, worth $141,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,253

Previous 3,290,843 98.93%

Holding current value

$141,012

Previous $21.9 Million 99.61%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.33 - $8.01 $7.59 Million - $26.1 Million	-3,255,590 Reduced 98.93%	35,253 $86,000
Q1 2025 May 15, 2025	SELL	$6.67 - $12.72 $4.76 Million - $9.07 Million	-713,196 Reduced 17.81%	3,290,843 $21.9 Million
Q4 2024 Feb 14, 2025	BUY	$11.35 - $18.82 $23.9 Million - $39.6 Million	2,106,699 Added 111.03%	4,004,039 $50.3 Million
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $18 Million - $26.4 Million	-1,021,738 Reduced 35.0%	1,897,340 $35 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $6.47 Million - $8.37 Million	313,062 Added 12.01%	2,919,078 $62.8 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $43.3 Million - $50.9 Million	1,656,111 Added 174.34%	2,606,016 $70.2 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $802,251 - $1.53 Million	47,810 Added 5.3%	949,905 $28.5 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $13.2 Million - $21 Million	874,999 Added 3229.26%	902,095 $18.5 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $1,094 - $1,557	66 Added 0.24%	27,096 $538,000
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $211,270 - $302,388	13,380 Added 98.02%	27,030 $463,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $211,575 - $310,674	13,650 New	13,650 $267,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $209,994 - $377,861	-15,957 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $26.1 Million - $43.7 Million	-1,213,541 Reduced 98.7%	15,957 $348,000
Q3 2021 Nov 16, 2021	SELL	$27.42 - $48.97 $164,273 - $293,379	-5,991 Reduced 0.48%	1,229,498 $36.8 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $229,642 - $275,325	-5,827 Reduced 0.47%	1,235,489 $54.7 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $1.56 Million - $2.37 Million	-35,994 Reduced 2.82%	1,241,316 $55.1 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $27.9 Million - $71.4 Million	1,199,043 Added 1531.99%	1,277,310 $70 Million
Q3 2020 Nov 16, 2020	BUY	$20.5 - $28.59 $96,309 - $134,315	4,698 Added 6.39%	78,267 $1.79 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $74,312 - $126,141	5,579 Added 8.21%	73,569 $1.54 Million
Q1 2020 May 14, 2020	BUY	$9.71 - $25.11 $660,182 - $1.71 Million	67,990 New	67,990 $948,000

Others Institutions Holding RCKT

# of Institutions

220

Shares Held

98.4M

Call Options Held

608K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $303M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Rocket Pharmaceuticals, Inc. Transaction History